Content area
Full text
Received Jan 12, 2017; Revised Mar 31, 2017; Accepted May 3, 2017
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Atherosclerosis has among its main determinants hypercholesterolemia characterized by increase of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) serum. This condition raises the important risk factors for cardiovascular disease (CVD) in the leading cause of mortality worldwide [1]. Cardiovascular disease, recently, in different geographical regions of the world is more prevalent in western countries and people with older age, thus giving a high incidence of mortality [2].
Over the last decades, in Brazil, 32% of deaths in adults represented the highest rate of death from cardiovascular disease in the Latin American region [3]. There are numerous factors that contribute to the abnormality of plasma lipids among which are modern lifestyle, high cholesterol, diet, and inadequate physical activity [4].
Many medications have been used to manage atherosclerosis over the years. These drugs on the market are very effective against deleterious effects of dyslipidemia acting mainly on the reduction of LDL-C and...